Fibrillex oral small molecule inhibitor of amyloid fiber formation regulatory update

Europe granted Orphan Drug designation for Fibrillex to treat secondary amyloidosis, a systemic form of amyloidosis associated with deposition of amyloid protein in the kidney, spleen, liver and adren...